NINIVAGGI DANIEL A 4
4 · Indivior Pharmaceuticals, Inc. · Filed May 14, 2026
Research Summary
AI-generated summary of this filing
Indivior (INDV) Director Daniel A. Ninivaggi Receives 6,518 RSU Award
What Happened
- Daniel A. Ninivaggi, a director of Indivior Pharmaceuticals, Inc. (INDV), was granted 6,518 restricted stock units (RSUs) on 2026-05-13. The award shows an acquisition price of $0.00 (no cash paid). This is a grant of equity compensation, not an open-market purchase or sale.
Key Details
- Transaction date: 2026-05-13 (reported on Form 4 filed 2026-05-14)
- Transaction type/code: Award/Grant (A)
- Shares/units granted: 6,518 RSUs; price reported $0.00
- Vesting: RSUs vest on the day immediately preceding the date of the annual meeting following the grant, subject to continued service (per footnote)
- Shares owned after transaction: Not specified in the provided excerpt of the filing
- Timeliness: Filing appears timely (period of report 2026-05-13; Form 4 filed 2026-05-14)
Context
- RSUs represent a contingent right to receive common stock at vesting (one share per RSU). They are commonly used as director compensation and do not involve an immediate cash outlay or open-market trading. Such grants are routine and reflect compensation practices more than an insider buying or selling shares.
Insider Transaction Report
Form 4
NINIVAGGI DANIEL A
Director
Transactions
- Award
Common Stock
[F1]2026-05-13+6,518→ 27,163 total
Footnotes (1)
- [F1]Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date.
Signature
/s/Alice Givens, Power of Attorney|2026-05-14